Liver cT(1) decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus

PURPOSE: Direct-acting antiviral therapies (DAAs) for treatment of chronic hepatitis C virus (HCV) have excellent rates of viral eradication, but their effect on regression of liver fibrosis is unclear. The primary aim was to use magnetic resonance imaging (MRI) and spectroscopy (MRS) to evaluate ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayaswal, Arjun N. A., Levick, Christina, Collier, Jane, Tunnicliffe, Elizabeth M., Kelly, Matthew D., Neubauer, Stefan, Barnes, Eleanor, Pavlides, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131342/
https://www.ncbi.nlm.nih.gov/pubmed/33247768
http://dx.doi.org/10.1007/s00261-020-02860-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131342/
https://www.ncbi.nlm.nih.gov/pubmed/33247768
http://dx.doi.org/10.1007/s00261-020-02860-5

Ejemplares similares